Susmed creates prescription‑grade therapeutic smartphone apps for chronic conditions such as insomnia, breast cancer, and kidney disease, delivering clinically validated, regulatory‑compliant digital treatments that patients can use outside traditional clinics. It also offers the Susmed System, a blockchain‑based platform that secures clinical trial data, automates verification, and reduces manual reconciliation, helping pharmaceutical companies lower development costs and accelerate trials.
Funding
Funding not disclosed
DFounders
Product
Problem
Clinical trials incur high costs and labor-intensive data verification, contributing to expensive drug prices, while patients with chronic conditions often lack convenient, evidence‑based digital therapies that can be accessed outside traditional healthcare settings.
Solution
Susmed addresses these challenges through two complementary offerings. First, it develops prescription‑grade therapeutic smartphone applications for conditions such as insomnia, breast cancer, kidney disease, and other chronic disorders, integrating clinical‑grade content and regulatory‑compliant validation. Second, Susmed provides the “Susmed System,” a blockchain‑based platform that secures trial data, automates verification, and reduces manual reconciliation, thereby lowering the cost and time of clinical development. Together, these solutions aim to make medical treatment more accessible for patients and to improve cost efficiency for pharmaceutical developers, supporting a sustainable healthcare ecosystem.
Target Audience
Primary customers are pharmaceutical manufacturers seeking cost‑effective clinical trial solutions and healthcare providers offering digital therapeutics to patients with chronic conditions.
Features
- Therapeutic mobile apps certified as medical devices under the Pharmaceuticals and Medical Devices Act, with built‑in clinical protocols and outcome tracking
- Multi‑condition portfolio (insomnia, breast cancer, kidney disease, tinnitus, pre‑menstrual syndrome) developed in partnership with pharmaceutical companies
- In‑app data collection and remote monitoring enabling continuous patient care without frequent clinic visits
- Susmed System’s proprietary blockchain ledger ensures immutable trial data, streamlines audit trails, and reduces manual data entry
- Automated data validation pipelines that integrate with sponsor’s clinical trial management systems
- Secure, encrypted cloud infrastructure for real‑time analytics and regulatory reporting